Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas.

It has been proposed that multiple rare variants in numerous genes collectively account for a substantial proportion of multifactorial inherited predisposition to a variety of diseases, including colorectal adenomas (CRA). We have studied this hypothesis by sequencing the adenomatous polyposis coli (APC) gene in 691 unrelated North American patients with CRAs and 969 matched healthy controls. Rare inherited nonsynonymous variants of APC were significantly overrepresented in patients who did not carry conventional pathogenic mutations in the APC or MutY homologue genes [non-familial adenomatous polyposis (FAP) non-MUTYH-associated polyposis (MAP) patients; 81 of 480, 16.9%] compared with patients with FAP or MAP (20 of 211, 9.5%, P = 0.0113), and this overrepresentation was highest in those non-FAP non-MAP patients with 11 to 99 CRAs (30 of 161, 18.6%, P = 0.0103). Furthermore, significantly more non-FAP non-MAP patients carried rare nonsynonymous variants in the functionally important beta-catenin down-regulating domain compared with healthy controls (32 of 480 versus 37 of 969, P = 0.0166). In silico analyses predicted that approximately 46% of the 61 different variants identified were likely to affect function, and upon testing, 7 of 16 nonsynonymous variants were shown to alter beta-catenin-regulated transcription in vitro. These data suggest that multiple rare nonsynonymous variants in APC play a significant role in predisposing to CRAs.

[1]  Robert W. Lucky,et al.  Just right , 1997 .

[2]  S. Gallinger,et al.  Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. , 1999, American journal of human genetics.

[3]  W F Bodmer,et al.  The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Bruce Winney,et al.  Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Kinzler,et al.  Association of the APC tumor suppressor protein with catenins. , 1993, Science.

[6]  I Tomlinson,et al.  Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. , 2000, Human molecular genetics.

[7]  W. Bodmer,et al.  Rare Variant Hypothesis for Multifactorial Inheritance: Susceptibility to Colorectal Adenomas as a Model , 2005, Cell cycle.

[8]  Jonathan C. Cohen,et al.  Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol , 2004, Science.

[9]  W F Bodmer,et al.  The ABC of APC. , 2001, Human molecular genetics.

[10]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[11]  H. Clevers,et al.  APC, Signal transduction and genetic instability in colorectal cancer , 2001, Nature Reviews Cancer.

[12]  S. Thibodeau,et al.  The APC E1317Q variant in adenomatous polyps and colorectal cancers. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  J. Peto,et al.  Prevalence of the APC E1317Q variant in colorectal cancer patients. , 2000, Cancer letters.

[14]  P. Radice,et al.  Prevalence of the E1317Q variant of the APC gene in Italian patients with colorectal adenomas. , 2002, Genetic testing.

[15]  H. Ostrer,et al.  Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC , 1997, Nature Genetics.

[16]  Alison L. Livingston,et al.  Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors , 2002, Nature Genetics.

[17]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[18]  W. Birchmeier,et al.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. , 1998, Science.

[19]  Siân Jones,et al.  Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH , 2003, The Lancet.

[20]  R. Fodde,et al.  The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. , 2002, Human molecular genetics.

[21]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.